NovaKonexus
| Private | |
| ISIN | 🆔 |
| Industry | Rehabilitation technology; digital health |
| Founded 📆 | |
| Founder 👔 | |
| Headquarters 🏙️ | , Toronto, Ontario , Canada |
Area served 🗺️ | |
Key people | Zen Koh (CEO)[1] |
| Members | |
Number of employees | |
| 🌐 Website | www |
| 📇 Address | |
| 📞 telephone | |
NovaKonexus is a Canadian healthcare technology venture associated with the KITE Research Institute at the Toronto Rehabilitation Institute and University Health Network (UHN).[1][2]
History
In December 2024, the KITE Research Institute announced the appointment of Zen Koh as Strategic Industry Advisor and Entrepreneur-in-Residence, and described him as the incoming chief executive officer of NovaKonexus Inc., characterised as a UHN spin-off focused on neurorehabilitation technologies.[1]
In January 2025, UHN highlighted Koh’s appointment in its internal news publication UHN on the Go.[3]
Overview
UHN Commercialization describes NovaKonexus as a venture developing rehabilitation-related technologies that integrate artificial intelligence, robotics and digital health, including device-based and remote-care approaches for neurorehabilitation, orthopaedics and geriatric care.[2]
Partnerships
According to UHN Commercialization, the venture works with clinical and industry partners, including Michels Kliniken GmbH & Co. KG and the Robotimize Group, alongside University Health Network, to support clinical validation and commercialization activities.[2]
Events and public presence
NovaKonexus has been listed as a participant in sector events. In 2025, representatives from NovaKonexus were listed in the programme for workshops at RehabWeek in Chicago, including Zen Koh and Johannes Michels (identified as a co-founder).[4]
The venture was also listed in the schedule for the Ontario Investment Summit (OIS) 2025 as part of an “Early Technology Showcase” entry described as “UHN – Medly + NovaKonexus”.[5]
Leadership
KITE identified Zen Koh as the incoming chief executive officer of NovaKonexus Inc. in its December 2024 announcement.[1]
UHN Commercialization identifies Milos R. Popovic as a scientific founder/inventor associated with the venture.[2]
References
- ↑ 1.0 1.1 1.2 1.3 "Zen Koh Appointed Strategic Industry Advisor at KITE, CEO/Entrepreneur-in-Residence for NovaKonexus". KITE UHN. 20 December 2024. Retrieved 20 February 2026.
- ↑ 2.0 2.1 2.2 2.3 2.4 "NovaKonexus™". UHN Commercialization. University Health Network. Retrieved 20 February 2026.
- ↑ "UHN on the Go: January 2025". University Health Network. 16 January 2025. Retrieved 20 February 2026.
- ↑ "Workshops & Learning Labs". RehabWeek 2025. Retrieved 20 February 2026.
- ↑ "OIS 2025 Schedule (PDF)" (PDF). Ontario Investment Summit. Retrieved 20 February 2026.
External links
This article "NovaKonexus" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:NovaKonexus. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
